News
Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.
Drugs in the Pipeline
The NDA is supported by two 2 positive interim analyses from the phase 3 REGENERATE trial that included patients with biopsy-proven stage 2 or 3 liver fibrosis due to NASH.
Drugs in the Pipeline
OPNT003 is an intranasal formulation containing the high affinity opioid antagonist, nalmefene.